Luminex-based virtual crossmatching for renal transplantation in South Africa

South African Medical Journal

Volumn 102, Issue 1, 2012, Pages 40-43

  Worsley, Catherine M ^a   Mayne, Elizabeth S ^a   Suchard, Melinda S ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; LUMIMNEX ANTIHLA ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; RECIPIENT; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SOUTH AMERICA; T LYMPHOCYTE;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; SENSITIVITY AND SPECIFICITY;

EID: 84255169937     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Zeevi A, Girnita A, Duquesnoy R. HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation. Immunol Res 2006;36:255-264.
2. Howell WM, Carter V, Clark B. The HLA system: immunobiology, HLA typing, antibody screening and crossmatching techniques. J Clin Pathol 2010; 63:387-390.
3. Shankarkumar U, Ghosh K, Mohanty D. The human leukocyte antigen (HLA) system. J Assoc Physicians India 2002;50:916-926.
4. Fuggle SV, McWhinnie DL, Chapman JR, Taylor HM, Morris PJ. Sequential analysis of HLA-class II antigen expression in human renal allografts - induction of tubular class II antigens and correlation with clinical parameters. Transplantation 1986;42:144-149.
5. Vaidya S, Partlow D, Susskind B, Noor M, Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead Luminex assay. Transplantation 2006;82:1524-1528.
6. Gebel HM, Moussa O, Eckels DD, Bray RA. Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums. Hum Immunol 2009;70:610-617.
7. Patel R, Terasaki P. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969;280:735-739.
8. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008;86:1864-1868.
9. Zeevi A, Lunz JG III, Shapiro R, et al. Emerging role of donor-specific anti-human leukocyte antigen antibody determination for clinical management after solid organ transplantation. Hum Immunol 2009;70:645-650.
10. Murata K, Baldwin WM. Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody mediated rejection. Transplantation Review (Orlando) 2009;23:139-150.
11. Bielmann D, Hönger G, Lutz D, Mihatsch MJ, Steiger J, Schaub S. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007;7:626-632.
12. Hartono C, Muthukumar T, Suthanthiran M. Noninvasive diagnosis of acute rejection of renal allografts. Curr Opin Organ Transplant 2010;15:35-41.
13. Cai J, Terasaki PI. Post-transplantation antibody monitoring and HLA antibody epitope identification. Curr Opin Immunol 2008;20:602-606.
14. Bogman MJ, Dooper IM. Banff classification for the histological diagnosis of renal graft rejection: what are the advantages? Nephrol Dial Transplant 1995;10:1291-1293.
15. Tait BD, Hudson F, Cantwell L, et al. Review article: Luminex technology for HLA antibody detection in organ transplantation. Nephrology 2009;14:247-254.
16. Lee P-C, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002;74:1192-1194.
17. http://www.tepnel.com/docs/content.asp?ID=1 (accessed 2 May 2011).
18. Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009;70:589-594.
19. Colombo MB, Haworth SE, Poli F, et al. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine. Cytometry B Clinical Cytometry 2007;728:465-471.
20. Amico P, Hönger G, Steiger J, Schaub S. Utility of the virtual crossmatch in solid organ transplantation. Current Opinion in Organ Transplantation 2009;14:656-661.
21. Zachary AA, Leffell MS. Detecting and monitoring human leukocyte antigen-specific antibodies. Hum Immunol 2008;69:591-604.
22. Poli F, Cardillo M, Scalamogna M. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach. Hum Immunol 2009;70:631-635.
23. Marrari M, Duquesnoy RJ. Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Transplant Immunol 2010;22:105-109.